IPHA Financials
Innate Pharma Sa - Financial statements & key metrics
Stock Price
$1.69
Market Cap
$152.94M
EPS
$-0.64
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$2.79M
Gross Profit
$2.79M
Operating Income
$-53.42M
Net Income
$-47.24M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$62.69M
Total Liabilities
$84.39M
Shareholders Equity
$-21.69M
Cash & Equivalents
$28.08M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-50.67M
CapEx
$134474
Free Cash Flow
$-50.81M
Profitability Metrics
Gross Margin
-384.4%
Operating Margin
-6.9%
ROE
-2.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is IPHA revenue?
IPHA's most recent quarterly revenue was $2.79M. Annual revenue can be calculated by summing the four most recent quarters.
Is IPHA profitable?
IPHA reported a loss of $47.24M in the most recent quarter.
What is IPHA market cap?
IPHA has a market capitalization of $152.94M, making it a small-cap stock.
Does IPHA have debt?
View IPHA's balance sheet for debt information.
What is IPHA cash flow?
IPHA's most recent quarterly free cash flow was $-50.81M.